Last reviewed · How we verify
Lidocaine 2 % Topical Cream
At a glance
| Generic name | Lidocaine 2 % Topical Cream |
|---|---|
| Sponsor | Universidade do Vale do Sapucai |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers (PHASE2)
- Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face (PHASE2, PHASE3)
- Multiprofen-CC to Reduce Pain in Hand Arthritis (PHASE3)
- Multidisciplinary Treatment of Chronic Vulvar Pain (NA)
- Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty (PHASE3)
- Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study (NA)
- Efficacy Of Combined Microneedling Plus Tretinoin In Treatment Of Stria Rubra (PHASE1)
- Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine 2 % Topical Cream CI brief — competitive landscape report
- Lidocaine 2 % Topical Cream updates RSS · CI watch RSS
- Universidade do Vale do Sapucai portfolio CI